journal cover

A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum

PLoS Medicine

Nov 1, 2005

Pierre L DruilheChristian Roussilhon

Get paper from

Abstract

Plasmodium falciparum merozoite surface protein 3 is a malaria vaccine candidate that was identified, characterised, and developed based on a unique immuno-clinical approach. The vaccine construct was derived from regions fully conserved among various strains and containing B cell epito...read more

Mentioned in this Paper

Cell Secretion
Aluminum sulfate
Aluminum potassium sulfate
Anatomical Maturation
Oleic Acids
Enzyme-Linked Immunosorbent Assay
Phosphoglycerate Dehydrogenase Activity
Immunoglobulin IgG3
Malaria Pathway
Parasites
Paper Details
References
  • References38
  • Citations73
1234
  • References38
  • Citations73
12345...

Similar Papers Found In These Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Malaria

Malaria is a mosquito-borne infectious disease that affects humans and other animals. Malaria causes symptoms that typically include fever, tiredness, vomiting, and headaches. Discover the latest research on malaria here,

Parasite Host Response

The parasite host response refers to the process by which the host organism responds to and interacts with the parasite it encounters. Discover the latest research on this topic in this feed.

PLOS Medicine eTOC

PLOS Medicine is a peer-reviewed journal covering medical sciences and published by the Public Library of Science. Discover the latest research from PLOS Medicine here.

Malaria Vaccines

Research for development of a malaria vaccine is currently underway to find an effective modality to control and eliminate the transmission of malaria. To date, no vaccine has been found to be efficacious in fighting against malaria. Here is the latest research on malaria vaccines.

Parasite Genetics

Parasite genetics is the study of the genetic material of parasites. Here is the latest research on parasite genetics.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Immunomodulating Agents

Immunomodulating agents are substances that stimulate or suppresse the immune system and may help the body combat againsts cancer, infection, or other diseases. Discover the latest research on immunomodulating agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Tetanus

Tetanus is a condition caused by the bacteria Clostridium tetani. The toxin impairs the function of motor neurons, leading to muscle spasms and tightness. Discover the latest research on Tetanus here.

Plasmodium Falciparum

Malaria remains a major cause of morbidity and mortality in the tropics, with the parasite Plasmodium falciparum responsible for the majority of the disease burden. Discover the latest research on Plasmodium falciparum.

General Medical Journal eTOCs

Discover the latest medical research in this collection of the top medical journals.

X-Linked Combined Immunodeficiency Diseases

X-linked severe combined immunodeficiency is caused by mutations in the common cytokine-receptor gamma chain, resulting in disruption of development of T lymphocytes and natural-killer cells. Here is the latest research.


Lymphopenia

Lymphopenia has been associated with autoimmune pathology and it has been suggested that lymphopenia-induced proliferation of naive T cells may be responsible for the development of immune pathology. Here is the latest research.


© 2019 Meta ULC. All rights reserved

A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum

PLoS Medicine

Nov 1, 2005

Pierre L DruilheChristian Roussilhon

PMID: 16262450

DOI: 10.1371/journal.pmed.0020344

Abstract

Plasmodium falciparum merozoite surface protein 3 is a malaria vaccine candidate that was identified, characterised, and developed based on a unique immuno-clinical approach. The vaccine construct was derived from regions fully conserved among various strains and containing B cell epito...read more

Mentioned in this Paper

Cell Secretion
Aluminum sulfate
Aluminum potassium sulfate
Anatomical Maturation
Oleic Acids

Similar Papers Found In These Feeds

Related Papers

Paper Details
References
  • References38
  • Citations73
1234
  • References38
  • Citations73
12345...

Get paper from

/papers/a-malaria-vaccine-that-elicits-in-humans/16262450